Jacob Gotlieb is a successful financial entrepreneur who is also referred to as the titan of healthcare investments. He recently added Altium Capital, a healthcare oriented business that is based in New York to his investments. Altium capital focuses on investment opportunities that are related to growth companies in the healthcare industry. Gotlieb invests in enterprises that offer advanced medical treatment and offer meaningful healthcare.
Recent investments by Altium Capital include Oragenics, Oramed Pharmaceuticals and Amarin Corporation. Oramed pharmaceuticals developed an oral treatment alternative for diabetes patients who normally have to inject their drugs. The technology was tested successfully and they were able to produce and release the orally ingestible insulin capsule. The Oramed team is made up of a successful management team that has vast experience in the pharmaceutical world and it enjoys the support of world-class scientific experts.
Amarin is a rapidly growing, innovative pharmaceutical company that is headquartered in Dublin,Ireland. Their main initiative is to develop drugs that improve on cardiovascular health. Their product development is based on the potential benefits of polyunsaturated fatty acids and lipid science expertise.
The main focus of Oragenics is in the development of novel antibiotics against infectious disease as well as the development of effective treatment against oral mucositis. The company was founded on the basis of replacement therapy which is the concept of replacing harmful bacteria with beneficial ones in order to restore the body back to health. The technology that Oragenics possesses can be helpful in tackling the issue of antibiotic resistance.
Previously, Gotlieb had founded Visium Asset Management in 2005. The company was worth over $8 billion and had at least 200 employees. However, after an insider trading scandal, the company had no option but to wind down and let go of the entire team leaving Gotlieb as the only Key executive.